DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Figitumumab
Figitumumab
HER2 Inhibition in Gastro-Oesophageal Cancer: a Review Drawing on Lessons Learned from Breast Cancer
Therapeutic Targeting of the IGF Axis
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
Insulin-Like Growth Factor Pathway and the Thyroid
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
Development and Preclinical Evaluation of Cixutumumab Drug
The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives
A Phase I/II Study of Erlotinib in Combination with the Anti
(INN) for Biological and Biotechnological Substances
Metabolische Signaturen Des Insulin-Like Growth Factor 1 Anhand Von Metabolom-Untersuchungen in Plasma Und Urin
Prescrire's Response
Focus on Approved and In-Clinical-Trial Monoclonal Antibodies
Clinical Development of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma Paul Gougis , Camille Moreau Bachelard, Maud Kamal, Hui K
Stembook 2018.Pdf
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
IUPAC Glossary of Terms Used in Immunotoxicology (IUPAC Recommendations 2012)*
WO 2013/169611 Al 14 November 2013 (14.11.2013) P O P C T
(12) Patent Application Publication (10) Pub. No.: US 2016/0184445 A1 Perroth Et Al
Top View
(INN) for Biological and Biotechnological Substances
HHS Public Access Author Manuscript
Treatment of Advanced Squamous Cell Carcinoma of the Lung: a Review
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
First-Line Treatment of Patients with Advanced Or Metastatic Squamous Non-Small Cell Lung Cancer: Systematic Review and Network Meta-Analysis
Surgical Management of Adrenocortical Carcinoma an Evidence-Based Approach
Clinical Applications and Future Direction of Insulin-Like Growth Factor-1 Receptor Pathway Blockade Wade T
Anti-IGF-1R Monoclonal Antibody
Supplementary Appendix
Anti-Insulin-Like Growth Factor Therapy in Breast Cancer
Candidate Biomarkers for Specific Intraoperative Near-Infrared
Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
International Nonproprietary Names for Pharmaceutical Substances (INN)
Combination Therapy Approaches to Target Insulin-Like Growth Factor Receptor Signaling in Breast Cancer
A Phase I Clinical Trial and Independent Patient-Derived Xenograft Study of Combined Targeted Treatment with Dacomitinib and Figitumumab in Advanced Solid Tumors
Monoclonal Antibodies in Non-Small-Cell Lung Cancer
Targeted Therapy for NSCLC–A Double-Edged Sword?
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
Metastatic Squamous Non-Small Cell Lung Cancer (Sqnsclc)
Pre-Treatment Levels of Circulating Free IGF-1 Identify NSCLC Patients Who Derive Clinical Benefit from Figitumumab
(2006.01) C07d 413/14
Primary Malignant Tumors of the Adrenal Glands
Effects on Cancer Therapy
211288Orig1s000
( 12 ) Patent Application Publication
Pfizer Halts Trial of Industry's Most Advanced IGF-1R Antibody
Monoclonal Antibodies: an Emerging Class of Therapeutics in Non Small Cell Lung Cancer
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
The Role of Epithelial Growth Factors and Insulin Growth Factors in the Adrenal Neoplasms
Emerging Therapeutic Approaches in the Management of Metastatic Castration-Resistant Prostate Cancer
Lessons to Learn for Adequate Targeted Therapy Development in Metastatic Colorectal Cancer Patients
(INN) for Biological and Biotechnological Substances
Molecular Predictors of Sensitivity to the Insulin-Like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871)
The Insulin-Like Growth Factor-I Receptor and Its Role in Thyroid- Associated Ophthalmopathy
Paclitaxel-Carboplatin-Pembrolizumab Combination (PC Pembrolizumab) Has Been Recently Authorised in This Indication
IGF1 Receptor and Thyroid-Associated Ophthalmopathy
Krill Final 8-2-2012
The Role of the Insulin-Like Growth Factor Axis in Osseous Metastasis
Targeting IGF-1R: Throwing out the Baby with the Bathwater?
Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies
Recommended INN: List 62
Assessment of the Evolution of Cancer Treatment Therapies
Randomized, Phase III Trial of Figitumumab in Combination with Erlotinib Versus Erlotinib Alone in Patients with Non- Adenocarcinoma Non-Small Cell Lung Cancer
Comprehensive Review of Targeted Therapy for Colorectal Cancer
Metformin Enhances the Therapy Effects of Anti-IGF-1R Mab Figitumumab to NSCLC
Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities
Portals of Discovery
Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases